Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1979-06-06
1981-06-02
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424180, 424310, 424326, A61K 3174, A61K 3170, A61K 31245, A61K 31155
Patent
active
042711444
ABSTRACT:
An ophthalmic solution for treating corneal edema concurrent with epithelial discontinuity, healing epithelial defects, and protecting against epithelial trauma containing electrolytes at only isotonic levels but containing hydrophilic macromolecules at such concentration that their collodial osmotic pressure is equal or greater than the imbibition pressure of corneal stroma.
REFERENCES:
patent: 2547653 (1951-04-01), Minnis et al.
patent: 3843782 (1974-10-01), Krezanoski et al.
patent: 3920810 (1975-11-01), Rankin
patent: 3935303 (1976-01-01), Khromov et al.
patent: 3978201 (1976-08-01), Khromov et al.
patent: 4003991 (1977-01-01), Khromon et al.
patent: 4039662 (1977-08-01), Hecht et al.
Handbook of Nonprescription Drugs, 5th ed., pp. 231, 232, 234 and 235 (1977)-A.P.A.
Holles Laboratories, Inc.
Huntington R. Danny
Robinson Douglas W.
LandOfFree
Dextran composition for controlling corneal hydration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dextran composition for controlling corneal hydration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dextran composition for controlling corneal hydration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1865048